160 related articles for article (PubMed ID: 32225025)
21. Upregulation of miR-519 enhances radiosensitivity of esophageal squamous cell carcinoma trough targeting PI3K/AKT/mTOR signaling pathway.
Zhang Y; Chen W; Wang H; Pan T; Zhang Y; Li C
Cancer Chemother Pharmacol; 2019 Dec; 84(6):1209-1218. PubMed ID: 31529206
[TBL] [Abstract][Full Text] [Related]
22. TKTL1 expression and its downregulation is implicated in cell proliferation inhibition and cell cycle arrest in esophageal squamous cell carcinoma.
Shi Z; Tang Y; Li K; Fan Q
Tumour Biol; 2015 Nov; 36(11):8519-29. PubMed ID: 26032094
[TBL] [Abstract][Full Text] [Related]
23. Cell death/proliferation roles for nc886, a non-coding RNA, in the protein kinase R pathway in cholangiocarcinoma.
Kunkeaw N; Jeon SH; Lee K; Johnson BH; Tanasanvimon S; Javle M; Pairojkul C; Chamgramol Y; Wongfieng W; Gong B; Leelayuwat C; Lee YS
Oncogene; 2013 Aug; 32(32):3722-31. PubMed ID: 22926522
[TBL] [Abstract][Full Text] [Related]
24. Sam68 promotes cellular proliferation and predicts poor prognosis in esophageal squamous cell carcinoma.
Wang Y; Liang L; Zhang J; Li M; Zhu J; Gong C; Yang L; Zhu J; Chen L; Ni R
Tumour Biol; 2015 Nov; 36(11):8735-45. PubMed ID: 26050229
[TBL] [Abstract][Full Text] [Related]
25. miR-143 inhibits tumor progression by targeting FAM83F in esophageal squamous cell carcinoma.
Mao Y; Liu J; Zhang D; Li B
Tumour Biol; 2016 Jul; 37(7):9009-22. PubMed ID: 26758433
[TBL] [Abstract][Full Text] [Related]
26. SEMA3B improves the survival of patients with esophageal squamous cell carcinoma by upregulating p53 and p21.
Tang H; Wu Y; Liu M; Qin Y; Wang H; Wang L; Li S; Zhu H; He Z; Luo J; Wang H; Wang Q; Luo S
Oncol Rep; 2016 Aug; 36(2):900-8. PubMed ID: 27349960
[TBL] [Abstract][Full Text] [Related]
27. MiR-214 promotes cell meastasis and inhibites apoptosis of esophageal squamous cell carcinoma via PI3K/AKT/mTOR signaling pathway.
Guanen Q; Junjie S; Baolin W; Chaoyang W; Yajuan Y; Jing L; Junpeng L; Gaili N; Zhongping W; Jun W
Biomed Pharmacother; 2018 Sep; 105():350-361. PubMed ID: 29864623
[TBL] [Abstract][Full Text] [Related]
28. DNMT1-microRNA126 epigenetic circuit contributes to esophageal squamous cell carcinoma growth via ADAM9-EGFR-AKT signaling.
Liu R; Gu J; Jiang P; Zheng Y; Liu X; Jiang X; Huang E; Xiong S; Xu F; Liu G; Ge D; Chu Y
Clin Cancer Res; 2015 Feb; 21(4):854-63. PubMed ID: 25512445
[TBL] [Abstract][Full Text] [Related]
29. Osthole inhibits the PI3K/AKT signaling pathway via activation of PTEN and induces cell cycle arrest and apoptosis in esophageal squamous cell carcinoma.
Zhu X; Li Z; Li T; Long F; Lv Y; Liu L; Liu X; Zhan Q
Biomed Pharmacother; 2018 Jun; 102():502-509. PubMed ID: 29579711
[TBL] [Abstract][Full Text] [Related]
30. Activation of the Dickkopf1-CKAP4 pathway is associated with poor prognosis of esophageal cancer and anti-CKAP4 antibody may be a new therapeutic drug.
Shinno N; Kimura H; Sada R; Takiguchi S; Mori M; Fumoto K; Doki Y; Kikuchi A
Oncogene; 2018 Jun; 37(26):3471-3484. PubMed ID: 29563607
[TBL] [Abstract][Full Text] [Related]
31. Plumbagin inhibits the proliferation and survival of esophageal cancer cells by blocking STAT3-PLK1-AKT signaling.
Cao YY; Yu J; Liu TT; Yang KX; Yang LY; Chen Q; Shi F; Hao JJ; Cai Y; Wang MR; Lu WH; Zhang Y
Cell Death Dis; 2018 Jan; 9(2):17. PubMed ID: 29339720
[TBL] [Abstract][Full Text] [Related]
32. MiR-141-3p is upregulated in esophageal squamous cell carcinoma and targets pleckstrin homology domain leucine-rich repeat protein phosphatase-2, a negative regulator of the PI3K/AKT pathway.
Ishibashi O; Akagi I; Ogawa Y; Inui T
Biochem Biophys Res Commun; 2018 Jun; 501(2):507-513. PubMed ID: 29738771
[TBL] [Abstract][Full Text] [Related]
33. nc886, an RNA Polymerase III-Transcribed Noncoding RNA Whose Expression Is Dynamic and Regulated by Intriguing Mechanisms.
Lee YS; Lee YS
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37239877
[TBL] [Abstract][Full Text] [Related]
34. Overexpression of SRC-3 promotes esophageal squamous cell carcinoma aggressiveness by enhancing cell growth and invasiveness.
Xu FP; Liu YH; Luo XL; Zhang F; Zhou HY; Ge Y; Liu C; Chen J; Luo DL; Yan LX; Mei P; Xu J; Zhuang HG
Cancer Med; 2016 Dec; 5(12):3500-3511. PubMed ID: 27781415
[TBL] [Abstract][Full Text] [Related]
35. Long noncoding RNA H19 is up-regulated in esophageal squamous cell carcinoma and promotes cell proliferation and metastasis.
Tan D; Wu Y; Hu L; He P; Xiong G; Bai Y; Yang K
Dis Esophagus; 2017 Jan; 30(1):1-9. PubMed ID: 27247022
[TBL] [Abstract][Full Text] [Related]
36. Long noncoding RNA PANDA promotes esophageal squamous carcinoma cell progress by dissociating from NF-YA but interact with SAFA.
Shi W; Wang Q; Bian Y; Fan Y; Zhou Y; Feng T; Li Z; Cao X
Pathol Res Pract; 2019 Oct; 215(10):152604. PubMed ID: 31495606
[TBL] [Abstract][Full Text] [Related]
37. Loss of miR-200b promotes invasion via activating the Kindlin-2/integrin β1/AKT pathway in esophageal squamous cell carcinoma: An E-cadherin-independent mechanism.
Zhang HF; Alshareef A; Wu C; Li S; Jiao JW; Cao HH; Lai R; Xu LY; Li EM
Oncotarget; 2015 Oct; 6(30):28949-60. PubMed ID: 26334393
[TBL] [Abstract][Full Text] [Related]
38. LncRNA-TUSC7/miR-224 affected chemotherapy resistance of esophageal squamous cell carcinoma by competitively regulating DESC1.
Chang ZW; Jia YX; Zhang WJ; Song LJ; Gao M; Li MJ; Zhao RH; Li J; Zhong YL; Sun QZ; Qin YR
J Exp Clin Cancer Res; 2018 Mar; 37(1):56. PubMed ID: 29530057
[TBL] [Abstract][Full Text] [Related]
39. MSP58 knockdown inhibits the proliferation of esophageal squamous cell carcinoma in vitro and in vivo.
Xu CS; Zheng JY; Zhang HL; Zhao HD; Zhang J; Wu GQ; Wu L; Wang Q; Wang WZ; Zhang J
Asian Pac J Cancer Prev; 2012; 13(7):3233-8. PubMed ID: 22994740
[TBL] [Abstract][Full Text] [Related]
40. Effects of PLCE1 gene silencing by RNA interference on cell cycling and apoptosis in esophageal carcinoma cells.
Zhao L; Wei ZB; Yang CQ; Chen JJ; Li D; Ji AF; Ma L
Asian Pac J Cancer Prev; 2014; 15(13):5437-42. PubMed ID: 25041015
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
